Compare DIT & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DIT | CSBR |
|---|---|---|
| Founded | 1981 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.1M | 81.0M |
| IPO Year | 1996 | 2015 |
| Metric | DIT | CSBR |
|---|---|---|
| Price | $72.90 | $7.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 510.0 | ★ 4.9K |
| Earning Date | 04-20-2026 | 03-12-2026 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | N/A | ★ 161.11 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,392,388,157.00 | $2,900,000.00 |
| Revenue This Year | N/A | $4.84 |
| Revenue Next Year | N/A | $11.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 5.30 | N/A |
| 52 Week Low | $68.00 | $5.50 |
| 52 Week High | $126.50 | $9.63 |
| Indicator | DIT | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 37.18 | 52.49 |
| Support Level | N/A | $5.69 |
| Resistance Level | $120.08 | $6.31 |
| Average True Range (ATR) | 1.49 | 0.36 |
| MACD | -0.56 | 0.04 |
| Stochastic Oscillator | 31.96 | 45.00 |
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.